RecruitingPhase 1NCT06199479

Radiologic Pathologic Correlation of Imaging to Distinguish True Progression From Pseudoprogression in Brain Malignancies


Sponsor

M.D. Anderson Cancer Center

Enrollment

25 participants

Start Date

Jun 4, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

To learn if advanced imaging methods can tell apart true progression (the disease has actually gotten worse) from pseudoprogression (the disease appears to have gotten worse, but it actually has not).


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study compares what brain MRI scans show with what the tumor actually looks like under the microscope in adults with brain tumors (gliomas). This helps researchers understand how well MRI scans can distinguish between true tumor growth, treatment-related changes, and scar tissue. **You may be eligible if...** - You are over 18 years old - You have had prior treatment for a brain tumor - You have a new or suspicious finding on a brain scan that may require further diagnosis - You are willing to attend all study visits and evaluations **You may NOT be eligible if...** - You are under 18 (pediatric brain tumors have a different profile and are excluded) - You are unwilling or unable to complete required visits Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREMRI Scan

Performed by MRI Scan

PROCEDURECT Scan

Performed by CT Scan

PROCEDUREBiopsy

Standard of Care Biopsy


Locations(1)

MD Anderson Cancer Center

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06199479